Novel Biomarker for Scleroderma Activity

OCR Number: 
OCR 5339
  • Scleroderma is a chronic disease characterized by progressive fibrosis of the skin, lung and other organs, as well as vascular injury and destruction.
  • Current treatments for this disease are poor and do not provide clinicians the ability to gauge disease activity.
  • A clear medical need exists for a way to identify and diagnose scleroderma earlier and treat it sooner
  • OCR 5339 is a novel serum-based biomarker assay that determines disease severity and provides a prediction of the progression of scleroderma.
Licensing Contact: